Taiyen Biotech Co Ltd
TWSE:1737
Dividends
Dividend Yield
Taiyen Biotech Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Taiyen Biotech Co Ltd
Taiyen Biotech Co Ltd have
decreased
by 0%.
Payout Ratio
Taiyen Biotech Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Taiyen Biotech Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Taiyen Biotech Co Ltd
| Average Annual Return | 2.07% |
| Standard Deviation of Annual Returns | 5.87% |
| Max Drawdown | -21% |
| Market Capitalization | 6.3B TWD |
| Shares Outstanding | 200 000 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Taiyen Biotech Co Ltd's latest stock split occurred on Dec 16, 2013
The company executed a 105-for-146 stock split, meaning that for every 146 shares held, investors received 105 new shares.
Before the split, Taiyen Biotech Co Ltd traded at 23.5058 per share. Afterward, the share price was about 23.3834.
The adjusted shares began trading on Dec 16, 2013. This was Taiyen Biotech Co Ltd's 3rd stock split, following the previous one in Aug 2, 2005.
